Patients with RA receiving anti‐TNF agents in combination with MTX, azathioprine, hydrocortisone, or mercaptopurine have exhibited a reduced frequency of ADA formation,13, 14, 15 which may contribute to the lower ADA levels seen over time. Here, TNF is linked to rheumatoid arthritis.